Sep 08, 2017 at European Journal of Cancer

A randomised phase II study of continuous versus stop-and-go S-1 plus oxaliplatin following disease stabilisation in first-line chemotherapy in patients with metastatic gastric cancer

By : European Journal of Cancer

A new Oncology Advance study finds benefits to stop-and-go chemotherapy in treating metastatic gastric cancer. Researchers found that continuous treatment boosted progression-free survival (the amount of time patients lived with no worsening of disease), but there was no difference between the two treatment regimens in overall survival (how long they lived), and quality of life favored the stop and go treatment protocol.

Read More
Sep 07, 2017 at Oxford Academic

A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer

By : Oxford Academic

In an international phase 3 trial, researchers find S-1 (a contemporary oral fluoropyrimidine)/ cisplatin and 5-fluorouracil (5-FU)/cisplatin are similar in efficacy and safety in patients with advanced stomach cancer.

Read More
Sep 06, 2017 at The Onc

Cancer Patients Benefit From Ongoing Distress Screening

By : The Onc

A study in the Journal of the National Comprehensive Cancer Network shows cancer patients assessed and treated as distressed visit emergency rooms and are hospitalized less often. 

Read More
Sep 05, 2017 at Max-Planck-Gesellschaft

Are stem cells the link between bacteria and cancer?

By : Max-Planck-Gesellschaft

Researchers discover how two types of stem cells in the stomach may be the link between Helicobacter pylori bacteria and gastric cancer. They found Helicobacter pylori sends the stomach’s stem cell renewal into overdrive, whose turnover is suspected to play a role in developing cancer.

Read More
Sep 04, 2017 at Dove Medical Press

Sensitization of gastric cancer cells to alkylating agents by glaucocalyxin B via cell cycle arrest and enhanced cell death

By : Dove Medical Press

A new study looks into reducing chemotherapy side effects when treating gastric cancer by using sensitizing agents in combination with therapeutic drugs.

Read More
SHARE